INSTITUTIONAL REVIEW BOARD (IRB)
HISTORY
In 1996, St. Paul’s Hospital Iloilo Ethics Committee was constituted. This was the beginning of Bioethics Committee. It was on June 27, 2006 that the Ethics Committee revised their existing policies and guidelines for the comprehensive and efficient review of researches that involved human participants. In cases of research and experimentation involving human subjects, the Committee made sure that the Clinical researches conform to the moral and scientific principles that justify the research.
The participants were well informed of the Study. Informed consents were signed, the subjects were free to terminate the study on any stage and for whatever reason and that the clinical research followed the national and international guidelines for the protection of the safety and well-being of the participants.
On November 1, 2007, the name of Ethics Committee was changed to St. Paul’s Hospital Ethics Review Board (IERB). In July 2014, the Administrator appointed Sr. Henrietta Esmero, SPC as a new member to replace Sr. Rowena Rodil, SPC who received a new assignment in Luzon. The Administrator also changed the name of St. Paul’s Hospital Ethics Review Board to Institutional Review Board Committee.
On February 27, 2015, Philippine Health Research Ethics Board released a memorandum addressing all the Ethics Review Committees to submit application for Accreditation in order to review clinical trials research protocols of drugs and devices for FDA registration. On April 30 of 2015, SPHI submitted an application for Level 3 Accreditation to the Philippines Health Research Ethics Board. This move was an evidence of SPHI’s commitment to submit to International and National Standard practices pertaining to the conduct of all types of researches.
IRB MIssion and vision
Mission
1. Receive and evaluate research proposals as to adherence to accepted ethical principles.
2. Assure that evaluation is based on local, national and international guidelines.
3. Update members on latest national and international guidelines.
Vision
A Christ-centered accredited board for ethical review and monitoring of researches.
IRB ORGANIZATIONAL CHART
The following are the members of the organized committee
As of May 1, 2024
CHAIRMAN:
DR. JAIME MANILA
CO-CHAIR:
DR. ROWENA COSCA
MEMBER-SECRETARY:
DR. MA. CECILIA FLORETE
MEMBERS:
SR. GERTRUDE CARYLS N. KUEBLER, SPC
DR. VENERIO GASATAYA, JR.
ATTY. JOSE MARI BENJAMIN TIROL
MARIA THELMA SERVIDAD
CHRISTOPHER TABSING
MA. ROMY ALEXIS CONSULTA
DR. RONALD LATAP
SPHI-IRB SOP 12th Edition
National and International guidelines
IRB "Flow CHART OF PROTOCOL SUBMISSIONS"
Frequently Asked Questions (FAQs)
Please reach us at sphirbresearch@gmail.com if you cannot find an answer to your question.
- Letter of Application & Complete Protocol
- Protocol Summary
- Investigator’s Brochure (for Clinical Trials)
- Data collection form/s
- Informed Consent Forms (English, Tagalog, and local dialect (Hiligaynon))
- CV (for clinical trials- Principal Investigator and his/her co-investigators), (for Researcher Initiated protocol-Researcher and Adviser).
- GCP Certificate of the Principal Investigator (PI) and his/her co-investigators
- GCP Certificate of the Principal Investigator (PI) and his/herco-investigators(Form 2.1)
- Valid PRC License
- COI Declaration and Confidentiality Agreement
- GANTT Chart (as necessary)
- Advertisement, Diary card and other related documents (for Clinical Trials)
- Case report form/s, trial Materials (for Clinical Trials)
- Certificate of Technical Review (for Researcher Initiated protocol)
- Insurance Certificate (for Clinical Trials)
- Technical review approval/endorsement of the Department
- Decision of Ethics Review if reviewed by other Research Ethics Committee/s
- Material Transfer Agreement (for Clinical Trials if applicable)
- Budget
- Clinical Trial Agreement- Draft is acceptable (for Clinical Trials)
- Letter of Approval from Hospital Administrator and Data Protection Officer
- Waiver of Informed Consent Form (if applicable)
The SPHI-IRB required to submit electronic copy of the protocol package for review and approval and three (3) hard copies should be submitted.
The validity of the ethical approval is for one (1) year only, the Principal Investigator/Researcher should apply for a Continuing Review.
The IRB cut-off is every 21st of the month (until 4:00pm only).
No, the IRB will only review those protocols whose SPHI is part of their study setting.
The IRB meeting is every 2nd Thursday of the month.
Meeting dates
IRB Meeting: Every 2nd Thursday of the month
June 12, 2025
July 10, 2025
August 7, 2025
September 11, 2025
October 09, 2025
November 21, 2025
December 11, 2025
CONTACT US
St. Paul's Hospital of Iloilo, Inc - Institutional Review Board 4th Floor Cancer Center Building
Email: sphirbresearch@gmail.com
Telephone No.: (033) 33727-42-49 Local 7306